Reckitt Sells Skin-Care Brand E45 To Karo In £200m Deal
Executive Summary
Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.
You may also be interested in...
Karo Strengthens Foot Care Offering As It Closes Lamisil Deal
Sweden's Karo has extended its footprint and geographical reach into new markets by closing its acquisition of topical antifungal brand Lamisil from Haleon.
New Owner Karo Invests Significantly In E45 In UK Including Relaunch And Line Extensions
Sweden's Karo Pharma is continuing to invest in its OTC portfolio, relaunching E45 in the UK supported by a seven figure marketing campaign and adding new lines to the popular skin-care brand.
Adcock Kept Cash Back For Two Major Deals, Prioritizes Partnerships
Adcock Ingram intends to continue seeking partnership deals with multinational firms, after failing to complete two significant acquisitions during its financial year ended 30 June 2022.